Pharmacy Policies and Procedures Manual

Last updated: Month, Day, Year

Last reviewed: Month, Day, Year

Links and references updated: June 21, 2016

Pharmacy Policies and Procedures Manual – Month, Day, Year

Table of Contents
1.0 Introduction............................................................................................................................................ 1

1.1 Definitions.......................................................................................................................................... 1

2.0 General Operations............................................................................................................................... 2

2.1 Pharmacy Information........................................................................................................................ 2

2.2 Staff Information................................................................................................................................ 3

2.3 Security.............................................................................................................................................. 4

2.3.1 Pharmacy Access....................................................................................................................... 4

2.3.2 Mandatory Pharmacist Presence................................................................................................ 4

2.3.3 Opening and Closing Procedures............................................................................................... 4

2.3.4 Keys............................................................................................................................................ 4

2.3.5 Alarm.......................................................................................................................................... 4

2.3.6 Lock and Leave.......................................................................................................................... 4

2.3.7 Hardware and Software Security................................................................................................ 5

2.3.8 Armed Robbery........................................................................................................................... 5

2.3.9 Pharmacy Break-ins or Burglaries.............................................................................................. 5

3.0 Dispensary Operations.......................................................................................................................... 5

3.1 Systems and Software....................................................................................................................... 5

3.1.1 Data Backup............................................................................................................................... 5

3.1.2 Netcare User ID and Password Security.....................................................................................6

3.1.3 Affiliate Agreements.................................................................................................................... 6

3.1.4 Systems and Software Training.................................................................................................. 6

3.2 Stock Layout or Planogram................................................................................................................ 6

3.3 Work Flow (Text and Diagram).......................................................................................................... 7

3.4 Prescription Filing System (Hardcopy and Electronic).......................................................................7

3.5 Retention of Prescription and Patient Records..................................................................................7

3.5.1 Retention of Prescriptions (Written, Electronic)..........................................................................8

ii
Pharmacy Policies and Procedures Manual – Month, Day, Year

3.5.2 Retention of Patient Records (Written, Electronic)......................................................................8

3.5.3 Retention of Disclosure of health information.............................................................................8

3.5.4 Offsite Storage............................................................................................................................ 8

3.6 Audit Trail - General (Text, Diagram)................................................................................................. 8

3.7 Prescribing......................................................................................................................................... 8

3.7.1 Adapting...................................................................................................................................... 9

3.7.2 Prescribing in an Emergency.................................................................................................... 10

3.7.3 Prescribing for Initial Access and Management of Ongoing Therapy........................................10

3.8 Documentation and Assessment Tools............................................................................................ 11

3.8.1 SOAP Notes............................................................................................................................. 11

3.8.2 Prescription Adaptation Notification.......................................................................................... 12

3.8.3 Collaborative Care Communication Form.................................................................................13

3.8.4 Informed Consent Form(s)........................................................................................................ 14

3.8.5 Record of Disclosure Form....................................................................................................... 14

3.9 Fax Standards Compliance.............................................................................................................. 14

3.10 Counselling.................................................................................................................................... 14

3.11 Sale of Schedule 2 and 3 Products................................................................................................14

3.12 Ordering Laboratory Tests and Use of Laboratory Data................................................................15

3.13 Repackaging Prescriptions............................................................................................................ 15

3.14 Delivery and Mailing of Prescriptions.............................................................................................16

3.15 Long Term Care Pharmacy............................................................................................................ 16

3.16 Compounding................................................................................................................................ 17

3.16.1 Non-Sterile Products............................................................................................................... 17

3.16.2 Sterile Products....................................................................................................................... 26

3.16.3 Contracts................................................................................................................................ 29

3.17 Narcotics and Controlled Substances............................................................................................ 30

3.17.1 Triplicate Prescription Program (TPP)....................................................................................30

3.17.2 Narcotics and Controlled Substances Receipts Report..........................................................31

iii
Pharmacy Policies and Procedures Manual – Month, Day, Year

3.17.3 Narcotics and Controlled Substances Inventory Management...............................................32

3.17.4 Managing Expired or Returned Stock.....................................................................................32

3.17.5 Loss or Theft Form.................................................................................................................. 32

3.17.6 Suspected Forgery.................................................................................................................. 33

3.17.7 Forgery Reporting Form.......................................................................................................... 33

3.17.8 Opioid Dependence Treatment...............................................................................................33

3.18 Benzodiazepines and Other Targeted Substances........................................................................35

3.19 Child Resistant Containers............................................................................................................ 36

3.20 Administration of Drugs by Injection.............................................................................................. 36

3.21 Cold Chain Management............................................................................................................... 36

3.21.1 Refrigerator Temperature Log................................................................................................. 37

3.22 Ordering......................................................................................................................................... 38

3.23 Prescription Balances or Owings................................................................................................... 38

3.24 Prescriptions Not Picked Up.......................................................................................................... 38

3.25 Inventory Management.................................................................................................................. 38

3.26 Special Access Programs (SAPs).................................................................................................. 38

3.27 Waste Management....................................................................................................................... 39

3.27.1 Expired Drugs/Returned Stock................................................................................................ 39

3.27.2 Sharps Disposal...................................................................................................................... 39

3.27.3 Needlestick Injury.................................................................................................................... 39

3.28 Quality Assurance and Safety........................................................................................................ 39

3.28.1 Drug Error (Drug Incident) Reporting......................................................................................39

3.28.2 Drug Error (Drug Incident) Follow-Up Process........................................................................40

3.28.3 Adverse Event Reporting........................................................................................................ 40

4.0 Patient Concerns................................................................................................................................. 40

5.0 Privacy Policy...................................................................................................................................... 40

5.1 Custodians of Health Information..................................................................................................... 41

5.2 Use and Disclosure of Health Information........................................................................................41

iv
Pharmacy Policies and Procedures Manual – Month, Day, Year

5.3 Disposal of Health Information......................................................................................................... 41

6.0 Confidentiality...................................................................................................................................... 42

6.1 Confidentiality Agreements.............................................................................................................. 42

6.2 Affiliate Agreements......................................................................................................................... 42

6.3 Handling Media Calls, Public Speaking, Press Releases................................................................42

7.0 Pharmacy Signage.............................................................................................................................. 42

8.0 Pharmacy Website............................................................................................................................... 42

9.0 Reference Library................................................................................................................................ 43

10.0 Code of Ethics................................................................................................................................... 45

11.0 Standards of Practice........................................................................................................................ 45

11.1 Standards for Practice for Pharmacists and Pharmacy Technicians.............................................45

11.2 Standards for the Operation of Licensed Pharmacies...................................................................45

12.0 Human Resources............................................................................................................................. 45

12.1 Job Descriptions............................................................................................................................ 46

12.2 Supervising Registered Pharmacy Interns.....................................................................................47

12.3 Staffing Levels............................................................................................................................... 47

12.4 Dress Code.................................................................................................................................... 47

12.5 Performance Appraisal.................................................................................................................. 47

12.6 Sick Leave..................................................................................................................................... 47

12.7 Leaves of Absence........................................................................................................................ 47

12.8 Vacation Requests......................................................................................................................... 47

12.9 Pandemic Preparedness Plan....................................................................................................... 48

12.10 Harassment in the Workplace...................................................................................................... 48

13.0 Business Operations.......................................................................................................................... 48

13.1 Internet and Electronic Communication......................................................................................... 48

13.2 Opening and Closing Cash............................................................................................................ 48

13.3 Charge Accounts........................................................................................................................... 48

13.4 Cheques........................................................................................................................................ 48

v
Pharmacy Policies and Procedures Manual – Month, Day, Year

13.5 Staff Purchases............................................................................................................................. 48

13.6 Telephones.................................................................................................................................... 48

13.7 Accounts Receivable..................................................................................................................... 49

13.8 Accounts Payable.......................................................................................................................... 49

13.9 Banking.......................................................................................................................................... 49

13.10 Pricing Policies............................................................................................................................ 49

13.11 Return Policies............................................................................................................................. 49

14.0 Contacts............................................................................................................................................ 49

14.1 Manager......................................................................................................................................... 49

14.2 Staff............................................................................................................................................... 49

14.2.1 Relief Pharmacists.................................................................................................................. 50

14.3 Alarm Company............................................................................................................................. 50

14.4 Wholesaler(s)................................................................................................................................. 50

14.5 Supplier(s)..................................................................................................................................... 50

14.6 Local Physicians............................................................................................................................ 50

14.7 Third Party:.................................................................................................................................... 51

14.8 Emergency Services...................................................................................................................... 51

14.8.1 Staff with CPR and First Aid Training......................................................................................51

vi
Pharmacy Policies and Procedures Manual – Month, Day, Year

1.0 Introduction
These operational procedures are specific to the provision of pharmacy services by [insert pharmacy
name here]. All other activities are encompassed in separate policies and procedures, sections of which
are complementary to these.

These procedures apply to all pharmacy employees who provide services on behalf of [insert pharmacy
name here].

These procedures will be reviewed every [insert time period]

1.1 Definitions
[Insert other definitions where applicable to your pharmacy or organization]

(a) “adverse drug event” means an unexpected and undesired incident that results in patient injury or
death or an adverse outcome for a patient, including injury or complication;

(b) “drug error” means an adverse drug event or a drug incident where the drug has been released to the

patient;

(c) “drug incident” means any preventable event that may cause or lead to inappropriate drug use or
patient harm. Drug incidents may be related to professional practice, drug products, procedures or
systems, and include:

(i) prescribing;

(ii) order communications;

(iii) product labeling, packaging, nomenclature;

(iv) compounding;

(v) dispensing;

(vi) distribution;

(vii) administration;

(viii) education;
1
Pharmacy Policies and Procedures Manual – Month, Day, Year

(ix) monitoring; and

(x) use;

(d) “drug therapy” means

(i) dispensing a Schedule 1 drug or blood product,

(ii) selling a Schedule 2 or Schedule 3 drug, or

(iii) prescribing a Schedule 1 drug or blood product;

(e) “individual” means an individual employed in a pharmacy and “employ” includes a volunteer
relationship;

(f) “patient” means any person to whom a pharmacist provides a service that is within the practice of
pharmacy;

(g) “patient’s agent” means a family member, caregiver or another person who has a close personal
relationship with the patient;

(h) “pharmacist” means a clinical pharmacist, a provisional pharmacist, a courtesy pharmacist or a

student pharmacist, unless the context requires otherwise;

(i) “pharmacist service” means any service that falls within the practice of pharmacy;

(j) “practice of pharmacy” and “pharmacy practice” mean the scope of practice described in section 3 of
schedule 19 to the Health Professions Act;

(k) “prescriber” means a regulated health professional who is authorized to prescribe schedule 1 drugs or
blood products;

(l) “professional relationship” means a relationship formed with a patient for the purpose of optimizing the
patient’s health and drug therapy;

2
Pharmacy Policies and Procedures Manual – Month, Day, Year

(m) “proprietor” means a person who owns, manages or directs the operation of a facility in which a
licensed pharmacy is located and exercises a significant degree of control over the management and
policies of the licensed pharmacy, or the conduct of the pharmacists and pharmacy interns, if any, who
are employed by the licensed pharmacy;

(n) “regulated health professional” means a health professional who practises under the terms of the
Health Professions Act or similar legislation that governs a profession in Alberta;

(o) “restricted activity” means any restricted activity referred to in section 16 of the Pharmacists
Profession Regulation;

(p) “Schedule 1 drug” means a Schedule 1 drug within the meaning of the Pharmacy and Drug Act;

(q) “Schedule 2 drug” means a Schedule 2 drug within the meaning of the Pharmacy and Drug Act;

(r) “Schedule 3 drug” means a Schedule 3 drug within the meaning of the Pharmacy and Drug Act

2.0 General Operations

2.1 Pharmacy Information
Pharmacy Name:

Pharmacy License #:

Address:

City:

Postal Code:

Hours of Operation:

Pharmacy Manager:

Pharmacy Proprietor(s) (e.g. owner, regional pharmacy director, director of operations):

Pharmacy Website(s):

2.2 Staff Information

Pharmacists

1.

2.

3.

3
Pharmacy Policies and Procedures Manual – Month, Day, Year

4.

5.

6.

Pharmacy Technicians

1.

2.

3.

Pharmacy Assistants

1.

2.

Other Staff

1.

2.

3.

4.

5.

6.

2.3 Security

2.3.1 Pharmacy Access

2.3.2 Mandatory Pharmacist Presence

2.3.3 Opening and Closing Procedures

Opening:

Closing:

4
Pharmacy Policies and Procedures Manual – Month, Day, Year

2.3.4 Keys
Procedure for key holders:

Procedure for relief pharmacists:

2.3.5 Alarm
Procedure:

Alarm Contacts:

2.3.6 Lock and Leave

Procedure:

Securing Schedule 2 products:

Securing Schedule 3 products:

Safe:

2.3.7 Hardware and Software Security

Procedure:

2.3.8 Armed Robbery

http://abpharmacy.ca/sites/default/files/BurglaryPreventionTips.pdf

Procedure:

5
Pharmacy Policies and Procedures Manual – Month, Day, Year

2.3.9 Pharmacy Break-ins or Burglaries

http://abpharmacy.ca/sites/default/files/BurglaryPreventionTips.pdf

Procedure:

3.0 Dispensary Operations

3.1 Systems and Software
Computer information:

3.1.1 Data Backup

Procedure:

Repair contact:

Supplies contact:

Dispensary software contact:

3.1.2 Netcare User ID and Password Security (DO NOT list user ids and
passwords here)
Systems User ID and Password Security:

Security Procedure:

Netcare User ID and Password Security

Security procedure:

3.1.3 Affiliate Agreements

Insert list of agreements with affiliate IT providers:

6
Pharmacy Policies and Procedures Manual – Month, Day, Year

3.1.4 Systems and Software Training

3.2 Stock Layout or Planogram

Supplies:

3.3 Work Flow (Text and Diagram)

http://www.qp.alberta.ca/574.cfm?page=2006_129.cfm&leg_type=Regs&isbncln=9780779758197

Role of Pharmacy Technician:

7
Pharmacy Policies and Procedures Manual – Month, Day, Year

Role of Pharmacy Assistant:

3.4 Prescription Filing System (Hardcopy and Electronic)

A prescription for a Schedule 1 drug may legally be filled for 12 months from the date on which the
prescription was written and may be refilled for 18 months past the date on which the prescription was
first filled.

New prescriptions:

Refill prescriptions:

Logged prescriptions:

3.5 Retention of Prescription and Patient Records

http://abpharmacy.ca/sites/default/files/RecordRetentionChart.pdf

3.5.1 Retention of Prescriptions (Written, Electronic)

Written prescriptions and transaction records for schedule 1 drugs that have been dispensed should be
filed systematically and retained for at least two years past the completion of therapy with regard to the
prescription or for 42 months, whichever is greater.

Procedure (including backup plan):

3.5.2 Retention of Patient Records (Written, Electronic)

The patient record must provide a history of all interactions required to be documented for a patient under
the Standards of Practice for Pharmacist and Pharmacy Technicians and must be maintained for a period
not less than 10 years after the last pharmacy service or two years past the age of majority, whichever is
greater.

Procedure (including access, retention and backup plan):

3.5.3 Retention of Disclosure of health information

When a custodian discloses a record containing individually identifying diagnostic, treatment and care
information without consent, the disclosing custodian must make a notation of the name of the recipient,
the date and purpose of the disclosure and a description of the information disclosed. The disclosure

8
Pharmacy Policies and Procedures Manual – Month, Day, Year

notation may be in paper or electronic form, may be put on the individual’s health or drug record or in a
book or “disclosure log.” This record is to be kept for 10 years following the date of disclosure.

Procedure:

3.5.4 Offsite Storage

Request form:

http://abpharmacy.ca/sites/default/files/RecordsMaintenance.pdf

Procedure:

3.6 Audit Trail - General (Text, Diagram)

3.7 Prescribing
http://abpharmacy.ca/standards-practice

3.7.1 Adapting
Refer to Standard 11-15 in the Standards of Practice for Pharmacists and Pharmacy Technicians

Informed Consent:

Adaptation notification form:

Communication (Refer to the Information Exchange Protocol of the electronic health record):

Documentation and rationale (refer to Standard 18 and Appendix A in Standards of Practice for
Pharmacists and Pharmacy Technicians):

Disclosure per Health Information Act:

9
Pharmacy Policies and Procedures Manual – Month, Day, Year

3.7.1.1 Restrictions on Altering a Dose

Procedure:

Documentation:

3.7.1.2 Renewing a Prescription

Procedure:

Documentation:

3.7.1.3 Therapeutic Substitution

Procedure:

Documentation:

3.7.2 Prescribing in an Emergency

Procedure:

Documentation:

3.7.3 Prescribing for Initial Access and Management of Ongoing Therapy

Procedure:

Documentation:

10
Pharmacy Policies and Procedures Manual – Month, Day, Year

3.8 Documentation and Assessment Tools

3.8.1 SOAP Notes

SUBJECTIVE/OBJECTIVE ASSESSMENT PLAN

Problem: Etiology / Risk Evaluate need for therapy; Recommended treatment plan: Patient Education
Factors evaluate current therapy; specific drug & non-drug
Subjective & Objective discuss treatment options therapy; therapeutic rationale;
Evidence further tests; follow-up

CURRENT MEDICATIONS GOALS & MONITORING

11
Pharmacy Policies and Procedures Manual – Month, Day, Year

3.8.2 Prescription Adaptation Notification

12
Pharmacy Policies and Procedures Manual – Month, Day, Year

3.8.3 Collaborative Care Communication Form

Collaborative Care Communication Form

TO: (Original Prescriber):__________________________________Date:________________

Address:______________________________________________________________________
Phone:________________________________________ Fax:___________________________

FROM: (Pharmacist):____________________________________________________________

Pharmacy Name:_______________________________________________________________

Address:______________________________________________________________________

Phone Number: _________________________________ Fax:___________________________

RE: Patient
Name:________________________________________________________________________

Address:______________________________________________________________________

Phone Number:_______________________ Alberta Health Care Number:__________________

DRUG THERAPY PROBLEMS

□ Drug therapy not required □ Adverse drug reaction

□ Needs additional drug therapy □ Drug dose too high

□ Drug therapy not working □ Noncompliance

□ Drug dose too low □ Other:_________________________

□ ACTION COMPLETED:

Pharmacist completing action:__________________________________________________

□ RECOMMENDATION:

□ ACTION REQUESTED – Please respond to pharmacy

Pharmacist requesting action:__________________________________________________

For fax back confirmation of action:

Original Prescriber’s Signature:____________________________________ Date:_______________

□ INFORMATION ONLY - No Immediate Action Necessary

Disclaimer: Insert company disclaimer regarding the privacy and security of information on this form. For example, “The information
contained above is intended for the recipient only and it is disclosed under the authority of the HIA for the purpose of providing
continuing treatment and care to the patient. Please notify sender if fax received in error.”

13
Pharmacy Policies and Procedures Manual – Month, Day, Year

3.8.4 Informed Consent Form(s)

Procedure:

Insert form(s) here

3.8.5 Record of Disclosure Form

Procedure:

Insert form(s) here or location of documentation in database

3.9 Fax Standards Compliance

http://abpharmacy.ca/sites/default/files/CommunicationOfMedicationPrescriptions.pdf

https://www.oipc.ab.ca/media/604264/guide_guidelines_on_facsimile_transmission_oct2002.pdf

3.10 Counselling
Procedure:

Documentation:

Insert form here or location in database for documentation

Audit trail:

3.11 Sale of Schedule 2 and 3 Products

Procedure:

Documentation:

3.12 Ordering Laboratory Tests and Use of Laboratory Data

Procedure:

14
Pharmacy Policies and Procedures Manual – Month, Day, Year

Documentation and Rationale (refer to Standard 18 and Appendix A in the Standards of Practice for
Pharmacists and Pharmacy Technicians):

Communication of results (Refer to the Information Exchange Protocol of the electronic health record):

3.13 Repackaging Prescriptions

Refer to Standards 7 and 21 in the Standards of Practice for Pharmacists and Pharmacy Technicians

Procedure:

Patient Records:

Quantity:

Repackaging area:

Labeling Requirements:

Audit Trail:

Quality assurance:

Documentation:

Storage:

15
Pharmacy Policies and Procedures Manual – Month, Day, Year

3.14 Delivery and Mailing of Prescriptions

Section 12.1 of the Pharmacy and Drug Regulations requires that where a prescription is not picked up at
the pharmacy by the patient or the patient’s agent, the pharmacy must document “the method of delivery
of the drug to the patient and the method of dealing with environmental concerns where appropriate.”

Procedure:

Documentation:

Audit trail: Insert delivery log template here

3.15 Long Term Care Pharmacy

Policies:

Procedure:

Patient assessments:

Collaboration with other health care providers:

Confidentiality agreements:

Patient records:

Supply:

Labels:

Audit trail:

16
Pharmacy Policies and Procedures Manual – Month, Day, Year

Documentation:

Delivery:

Storage:

Disposal:

Contracts:

Quality assurance:

Billing:

3.16 Compounding
Refer to Standard 10 in Standards of Practice for Pharmacists and Pharmacy Technicians.

Refer to Standard 7 in Standards for the Operation of Licensed Pharmacies.

http://www.hc-sc.gc.ca/dhp-mps/compli-conform/gmp-bpf/docs/pol_0051-eng.php#a7

http://napra.ca/Content_Files/Files/Guidelines_to_Pharmacy_Compounding_Oct2006.pdf

3.16.1 Non-Sterile Products

3.16.1.1 Compounding area

The compounding area should be kept clean, sanitary, and orderly to prevent contamination and/or mix-
ups among ingredients and containers. Food and drink should not be placed within the compounding
area. Only one compound should be prepared within the compounding area at a time.

Compounding area:

Sanitation schedule and agents (i.e. isopropyl alcohol) used:

17
Pharmacy Policies and Procedures Manual – Month, Day, Year

3.16.1.2 Equipment:

Equipment should be kept clean, protected from contamination, properly maintained, and used
appropriately. The equipment should be periodically checked for proper functioning and calibrated.
Always inspect equipment for cleanliness and proper functioning before starting to compound.

Equipment cleaning and maintenance procedure:

Measuring equipment calibration and documentation:

3.16.1.3 Personnel

During the compounding process, only a limited number of personnel should be within the compounding
area. Compounding should be completed or supervised by a regulated pharmacy technician or
pharmacist who has the appropriate compounding knowledge and skills. Minimum requirements for
health conditions (i.e. open lesions) and hygienic behaviours (hand-washing, attire) of personnel should
be set in order to prevent drug contamination and provide personnel protection.

Personnel health, hygiene and attire:

Protective gear (gloves, mask):

WHMIS training and MSDS location (MSDS should be readily available to personnel):

3.16.1.4 Formulas

Standard 10: Each time a pharmacist or a pharmacy technician compounds a drug or a blood product, the
pharmacist or the pharmacy technician must ensure that the compounded drug or blood product is
prepared according to:

a) a written compounding formula, and

b) a written preparation process

Standard 10.2: Whenever possible a pharmacist or a pharmacy technician who compounds a drug or
blood product must do so according to a compounding formula from a reputable source such as a
pharmacy text or peer-reviewed published journal.

Standard 10.3: If no formula is available, a pharmacist must use the pharmacist’s pharmaceutical
knowledge, including but not limited to knowledge in pharmaceutics, pharmacology, medicinal chemistry
and therapeutics to create a formula and reduce it to writing.

Master formula documentation:

http://abpharmacy.ca/sites/default/files/CompoundForumulaPreparationInstr_web.pdf

18
Pharmacy Policies and Procedures Manual – Month, Day, Year

19
Pharmacy Policies and Procedures Manual – Month, Day, Year

Standard 10.4: Whenever possible, a pharmacist or a pharmacy technician who compounds a drug or
blood product must ensure that deviations from the written preparation process are avoided.

Standard 10.7: A pharmacist or a pharmacy technician who deviates from the written process while
preparing a compound must ensure that the deviation and the rationale for it are documented.

Procedure for deviating from formulas:

3.16.1.5 Pre-compounding procedure:

Standard 10.8: A pharmacist or a pharmacy technician who compounds a drug or blood product must
ensure that all ingredients used in compounding have an approved designation of standard of quality
such as:
a) BP (British Pharmacopeia),
b) USP (United States Pharmacopeia), or
c) NF (National Formulary)
unless such a designation does not exist for the ingredient.

For ingredients that do not have an expiration date, assign a conservative expiration date to the ingredient
that is no later than 3 years after receipt.

All ingredients used in compounding should be stored in a clean area and at a temperature/humidity level
appropriate for the ingredient. Ingredients should be handled in a way that will prevent confusion and
cross contamination with other ingredients.

Inspect all ingredients prior to using them in a compound preparation. For each ingredient, confirm the
identity, assess the quality by examining its organoleptic properties (size, shape, color, homogeneity,
consistency, purity, microbial growth, smell, taste, touch), and expiration date.

Possible signs of instability:

 Solid dosage forms (capsules, tablets, powder, granules, effervescent tablets): cracks or chips on
tablet surfaces; mottling or discoloration; fusion; appearance of liquid droplets or crystal deposits;
clumping; swelling of mass; gas formation; microbial growth

 Liquid dosage forms (solutions, elixirs, syrups, emulsions, suspensions, tinctures): microbial
growth; cloudiness/precipitation; emulsion separation; non-resuspendable caking of suspension;
discoloration; turbidity; gas formation; odor

 Semisolid dosage forms (cream, ointment, suppositories): discoloration; change in consistency;

odor; crystal deposits; microbial growth; granule formation; hardening; separation

Prior to compounding:

1. Retrieve master formula

2. Inspect equipment (function and cleanliness)

20
Pharmacy Policies and Procedures Manual – Month, Day, Year

3. Gather and inspect ingredients (quality, identity, expiration date)

4. Place all ingredients to be weighed on the left of scale

5. All ingredients should be labeled to prevent confusion

6. Have compounding documentation forms available

Pre-compounding procedure:

3.16.1.6 Compounding procedures and documentation:

Documentation:

Standard 10.11: In addition to the documentation requirements for dispensing a drug or blood product in
Standards 18.1 and 18.2, a pharmacist or a pharmacy technician who compounds a drug or blood
product must ensure that a record is created that includes the:

a) name, lot number, expiry date and quantity of each ingredient used to prepare the compounded drug or
blood product;

b) formula used to prepare the compounded drug or blood product

c) beyond-use date assigned to the compounded drug or blood product; and

d) a clear audit trail that identifies all individuals who were involved in the preparation and verification of
the compounded drug or blood product, and the role of each individual.

Documentation form:

Audit trail:

Bulk preparations:

Assigning batch #s:

http://abpharmacy.ca/sites/default/files/CompoundPreparationDocumentation_web.pdf

21
Pharmacy Policies and Procedures Manual – Month, Day, Year

22
Pharmacy Policies and Procedures Manual – Month, Day, Year

3.16.1.7 Product assessment:

Standard 10.14: A pharmacist or a pharmacy technician must perform a final check of all compounded
drugs or blood products to be satisfied that each step in the compounding process has been completed
accurately by verifying that:

a) the drug, strength, manufacturer and quantity compounded are correct;

b) the compound was correctly prepared according to the written formula and process;

c) calculations and measures were completed accurately;

d) the label includes the information required in these standards; and

e) the package and packaging material are appropriate to protect the compounded product from light and
moisture as necessary and to minimize the potential for interaction between a drug or health care product
and the container.

Standard 10.15: Whenever possible, a final check of a compounded product must be performed by a
pharmacist or a pharmacy technician who did not prepare the label, complete calculations, select the
ingredients from stock or prepare the compound.

The final product should be examined for quality assurance. Examine the compounded preparation’s
quantity and organoleptic properties (size, shape, color, consistency, homogeneity, purity, smell, taste,
touch). Compare the description of your preparation with the description on the master formula.
Document your description of the final product.

Post compounding procedure:

1. Inspect final product (organoleptic properties)

2. Confirm quantity of final product

3. Verify ingredients used

4. Verify calculations

5. Compare the preparation instructions used against the master formula

6. Compare your final product’s description against the master formula

7. Ensure proper packaging and labeling

8. Assign beyond-use date

9. Ensure proper storage

10. Complete a documentation form that records the ingredients used, formula used, beyond-use
date assigned, and audit trail

Post compounding procedure:

23
Pharmacy Policies and Procedures Manual – Month, Day, Year

3.16.1.8 Packaging:

The packaging should protect the compound from light and moisture and be appropriate for the
compound. Packaging containers and closures should be stored appropriately to prevent contamination
and maintain cleanliness.

Packaging requirements:

3.16.1.9 Labeling:

The label of the compound should include, in addition to the requirements set out in Standard 7, the list of
active ingredients and strength, dosage form, batch # (if applicable), storage instructions and beyond-use
date.

Labeling requirements:

Beyond use date assignment:

According to United States Pharmacopeia (2012)1:

 Beyond-use dates (BUD) should be assigned conservatively. When assigning a BUD,

compounders shall consult and apply drug-specific and general stability documentation
and literature when available and shall consider:
o the nature of the drug and its degradation mechanism
o the dosage form and its components
o the potential for microbial proliferation in the preparation
o the container in which it is packaged
o the expected storage conditions
o the intended duration of therapy
 When a manufactured product is used as the source of the active pharmaceutical
ingredient for a non-sterile compounded preparation, the product expiration date cannot
be used solely to assign a BUD for the compounded preparation.
 At all steps in the compounding, dispensing, and storage process, the compounder shall
observe the compounded drug preparation for signs of instability.
 In the absence of stability information that is applicable to a specific drug and
preparation, the following table presents maximum beyond-use dates recommended for
non-sterile compounded drug preparations that are packaged in tight, light-resistant
containers and stored at controlled room temperature, unless otherwise indicated.
Drugs or chemicals known to be labile to decomposition will require shorter BUDs.

By Type of Formulation

1
United States Pharmacopeial Convention. (2012, August 1). Chapter 795 Pharmaceutical Compounding—Nonsterile Preparations.
Retrieved from USP-NF Online: www.uspnf.com

24
Pharmacy Policies and Procedures Manual – Month, Day, Year

For Non-aqueous Formulations: The BUD is not later than the time remaining until the
earliest expiration date of any active pharmaceutical
ingredient or 6 months, whichever is earlier.

For Water-Containing Oral The BUD is not later than 14 days when stored at
Formulations: controlled cold temperatures.

For Water-Containing The BUD is not later than 30 days.

Topical/Dermal and Mucosal
Liquid and Semisolid
Formulations:

(United States Pharmacopeial Convention, 2012)

3.16.1.10 Storage:

3.16.1.11 Pricing guidelines:

3.16.1.12 Disposal and clean up procedure:

3.16.2 Sterile Products

3.16.2.1 Aseptic area:

Laminar flow hood operations, maintenance, and documentation:

Opening and closing procedures:

Environmental monitoring and documentation:

Sanitation schedule and agents used:

Sanitation documentation:

3.16.2.2 Equipment:
25
Pharmacy Policies and Procedures Manual – Month, Day, Year

Equipment cleaning and maintenance procedure:

Measuring equipment calibration and documentation:

3.16.2.3 Personnel:

Personnel training requirements:

Personnel validation process:

Untrained personnel policies:

Personnel health, hygiene and attire:

Hand washing:

Protective gear used:

WHMIS training and MSDS location:

3.16.2.4 Formulas:

Master formula documentation:

Procedure for deviating from formulas:

3.16.2.5 Pre-compounding procedure:

Ingredient assessment:

Pre-compounding procedure:

26
Pharmacy Policies and Procedures Manual – Month, Day, Year

Cytotoxic agents:

3.16.2.6 Compounding procedure and documentation:

Aseptic techniques:

Sterility testing procedure:

Documentation form:

Audit trail:

Bulk preparations:

Assigning batch #s:

3.16.2.7 Product assessment:

Post compounding procedure:

3.16.2.8 Packaging:

3.16.2.9 Labeling:

3.16.2.10 Storage:

3.16.2.11 Pricing guidelines:

3.16.2.12 Disposal and clean up procedure:

27
Pharmacy Policies and Procedures Manual – Month, Day, Year

3.16.3 Contracts
http://abpharmacy.ca/sites/default/files/CompoundingAndRepackagingAgreement.doc

Insert compounding contract template

28
Pharmacy Policies and Procedures Manual – Month, Day, Year

3.17 Narcotics and Controlled Substances

Procedure for narcotic signing authority:

Prescription Regulations Chart:

http://abpharmacy.ca/sites/default/files/PrescriptionRegulations.pdf

3.17.1 Triplicate Prescription Program (TPP)

Pharmacy Resources (Information for the Pharmacist)

http://abpharmacy.ca/triplicate-prescription-program

Stolen TPP Pads

http://abpharmacy.ca/triplicates-stolenmissing

Procedure:

Frequently Asked Questions

http://abpharmacy.ca/faq?shs_term_node_tid_depth=191

Information for the Prescriber

http://www.cpsa.ca/wp-content/uploads/2015/09/Information_for_prescribers_and_dispensers.pdf?
a81143

Handling Logged Prescriptions and Refills

Procedure:

29
Pharmacy Policies and Procedures Manual – Month, Day, Year

3.17.2 Narcotics and Controlled Substances Receipts Report

Pharmacy Narcotic and Controlled Drug

Record of Receipts of Narcotics and Controlled Drugs
Register

Name of Drug or
Quantity Received From Quantity Received From
Specialty Name of Drug or
Date Date
Specialty

30
Pharmacy Policies and Procedures Manual – Month, Day, Year

3.17.3 Narcotics and Controlled Substances Inventory Management

Procedure for narcotic and controlled substances counts:

Procedure for storage of narcotics and controlled substances:

3.17.4 Managing Expired or Returned Stock

Procedure for Return (include template for documenting returned products from patients and expired
products in the pharmacy):

Procedure for Disposal (include procedure for requesting authorization from Health Canada for
destruction):

For all controlled substances - with the exception of targeted substances - pharmacists, hospitals, nursing
stations and practitioners must apply for destruction through the Office of Controlled Substances in
Ottawa.
The Compliance Unit requires the following by letter:

 date of the request

 full name and address of the pharmacy
 list of drugs by name including quantity, strength, lot# and expiry date
 one list for products from the pharmacy inventory and a separate list for products returned to the
pharmacy by patients
 the name and license number of the pharmacist requesting permission to destroy the items

There is a dedicated phone and fax line for inquiries.

Telephone: (613) 954-1541

Fax: (613) 957-0110

The office prefers a fax over a phone call if the fax lists the drugs to be destroyed.

3.17.5 Loss or Theft Form

http://www.hc-sc.gc.ca/hc-ps/substancontrol/substan/compli-conform/loss-perte/index-eng.php

http://www.hc-sc.gc.ca/hc-ps/alt_formats/hecs-sesc/pdf/substancontrol/substan/compli-conform/loss-
perte/form_4010-eng.pdf

Procedure:
31
Pharmacy Policies and Procedures Manual – Month, Day, Year

3.17.6 Suspected Forgery

Procedure:

3.17.7 Forgery Reporting Form

http://www.hc-sc.gc.ca/hc-ps/alt_formats/hecs-sesc/pdf/substancontrol/substan/compli-conform/loss-
perte/forgery_rep-rap-fau_ordonance.pdf

ACP forgery reporting form

http://abpharmacy.ca/forgery-alerts

Procedure:

3.17.8 Opioid Dependence Treatment

https://abpharmacy.ca/sites/default/files/ODTGuidelines.pdf

3.17.8.1 General

Prescription authentication procedure:

Prescriber exemption verification:

Patient verification procedure:

Patient assessment and documentation:

Patient pick up schedule:

New patient agreement (i.e. expectations, obligations, pick up schedule, identification):

32
Pharmacy Policies and Procedures Manual – Month, Day, Year

3.17.8.2 Administration

Witnessing administration:

Initial dosing of Suboxone:

Missed dose:

Lost/stolen dose:

Spoiled dose:

Vomited dose (methadone and Suboxone):

Withholding dose:

Administration records:

Physician collaboration:

Dispensing container:

3.17.8.3 Preparation

Methadone preparation (equipment, audit trail, and documentation):

Bulk compounding (concentration, quantity, labeling, stability, documentation):

Storage location of medications:

Disposal:

33
Pharmacy Policies and Procedures Manual – Month, Day, Year

3.17.8.4 Carries

Patient eligibility:

Requirements and restrictions:

Agreement:

Labelling and packaging:

Signature and documentation:

Delivery and documentation:

Bottle return and documentation:

Alternative witness agreement:

3.18 Benzodiazepines and Other Targeted Substances

http://abpharmacy.ca/benzodiazepines-other-targeted-substances

Procedure (diversion, receipt, storage, records maintenance, refills, transfers, destruction):

3.19 Child Resistant Containers

3.20 Administration of Drugs by Injection

Refer to Standards 16-17 in the Standards of Practice for Pharmacists and Pharmacy Technicians

http://abpharmacy.ca/authorization-inject

34
Pharmacy Policies and Procedures Manual – Month, Day, Year

http://abpharmacy.ca/seasonal-influenza-information

Procedure:

Informed consent:

3.21 Cold Chain Management

http://abpharmacy.ca/sites/default/files/ColdChainManagement.pdf

3.21.1 Refrigerator Temperature Log

http://www.albertahealthservices.ca/assets/info/hp/cdc/if-hp-cdc-temp-mntrng-log.pdf

3.22 Ordering
Procedure:

Wholesalers:

Special order:

3.23 Prescription Balances or Owings

Procedure:

3.24 Prescriptions Not Picked Up

Procedure:

3.25 Inventory Management

Maintenance:

35
Pharmacy Policies and Procedures Manual – Month, Day, Year

Short-dated/expired stock:

3.26 Special Access Programs (SAPs)

Procedure:

3.27 Waste Management

3.27.1 Expired Drugs/Returned Stock

Procedure:

3.27.2 Sharps Disposal

Procedure:

3.27.3 Needlestick Injury

Prevention:

Procedure for managing injuries:

3.28 Quality Assurance and Safety

(a) Within 24 hours of initial discovery, the licensee must ensure that any suspected drug error is
investigated and, if verified, is documented.

(b) The staff member(s) involved in the drug error must document an account of the error as soon as
possible after the discovery. If the staff member(s) involved are not on duty at the time of discovery, the
staff member who discovers the drug error must initiate the documentation.

(c) Drug error documentation must:

(i) be in a format that can be easily audited and reviewed, and

36
Pharmacy Policies and Procedures Manual – Month, Day, Year

(ii) be maintained for at least 10 years after the error is discovered.

(d) The documentation must include a description of factors contributing to the drug error and actions
taken to prevent recurrence.

(e) The report must clearly identify whether it relates to a drug incident or an adverse drug event.

3.28.1 Drug Error (Drug Incident) Reporting

Drug Error (Drug Incident) Reporting Form:

http://abpharmacy.ca/drug-error-management

Procedure for preventing, reporting, investigating, documenting and evaluating drug errors (drug
incidents):

Procedure for dealing with complaints or concerns:

3.28.2 Drug Error (Drug Incident) Follow-Up Process

http://abpharmacy.ca/sites/default/files/DrugIncidentQuarterlyReview.pdf

The licensee must, at least quarterly:

(a) review the drug-error reports for the licensed pharmacy to evaluate whether practice changes or
preventative measures are required to prevent future drug errors; and

(b) assess whether any changes implemented as a result of a drug error were successful in advancing
patient safety.

Procedure to conduct regular review of procedures to prevent drug errors (drug incidents):

3.28.3 Adverse Event Reporting

http://www.hc-sc.gc.ca/dhp-mps/alt_formats/pdf/medeff/report-declaration/ser-des_form-eng.pdf

4.0 Patient Concerns

http://abpharmacy.ca/sites/default/files/PatientConcernPoster.pdf

Complaints procedure:
37
Pharmacy Policies and Procedures Manual – Month, Day, Year

5.0 Privacy Policy

http://abpharmacy.ca/federal-legislation

http://abpharmacy.ca/provincial-legislation

5.1 Custodians of Health Information

https://abpharmacy.ca/sites/default/files/HIAGuide.pdf

Custodians of health information (list and define where appropriate)

a) Pharmacists:

b) Pharmacy Managers:

c) Affiliates (specify):

d) Others (specify):

5.2 Use and Disclosure of Health Information

https://abpharmacy.ca/sites/default/files/HIAGuide.pdf

Procedure (define limitations on type, access and use of health information):

Procedure for disclosure:

Procedure for documentation and retention of record of disclosure:

5.3 Disposal of Health Information

Procedure:

Shredding:

38
Pharmacy Policies and Procedures Manual – Month, Day, Year

6.0 Confidentiality
6.1 Confidentiality Agreements

6.2 Affiliate Agreements

6.3 Handling Media Calls, Public Speaking, Press Releases

Procedure:

7.0 Pharmacy Signage

□ Pharmacy hours posted (must be posted in public view)

□ Pharmacy license (must be posted in public view)

□ Code of Ethics poster (must be posted in public view)

http://abpharmacy.ca/sites/default/files/CodeOfEthics.pdf

□ Patient Concerns poster (must be posted in public view)

http://abpharmacy.ca/sites/default/files/PatientConcernPoster.pdf

□ Patient Information Collection poster

http://abpharmacy.ca/sites/default/files/PatientInfoCollection.pdf

□ Returned medication cards

http://abpharmacy.ca/sites/default/files/StandardsMiniPoster.pdf

□ Relevant Certification (e.g. CDE, CGP)

8.0 Pharmacy Website

http://abpharmacy.ca/manage-your-pharmacy

Requirements:

Procedure for updating:

39
Pharmacy Policies and Procedures Manual – Month, Day, Year

9.0 Reference Library

Please refer to the attached link for the up-to-date list of required references in the following categories.

http://abpharmacy.ca/sites/default/files/RequiredReferences.pdf

1. Federal/Provincial Professional Legislation

2. Canadian Compendium

3. Drug Interaction Text

4. Therapeutic Text

5. Dispensatory/Foreign Drug Text

6. Medical Dictionary

7. OTC Reference

8. Natural Health Products and Alternative Therapies Text

10.0 Code of Ethics

The Code of Ethics must be posted in public view.

40
Pharmacy Policies and Procedures Manual – Month, Day, Year

http://abpharmacy.ca/code-ethics

Policy to disclose services not available because of conscientious objection (Principle V.  Respect
each patient’s right to healthcare):

A pharmacist shall assist each patient to obtain appropriate pharmacy services from another pharmacist
or health professional within a timeframe fitting the patient’s needs if that pharmacist is unable to provide
the pharmacy service or will not provide the service due to a conscientious objection. A pharmacist will
arrange the condition of his/her practice so that the care of his/her patients will not be jeopardized when
he/she will not provide certain pharmacy services due to a conscientious objection.

Insert policy and procedure here

11.0 Standards of Practice

11.1 Standards for Practice for Pharmacists and Pharmacy
Technicians
http://abpharmacy.ca/standards-practice

11.2 Standards for the Operation of Licensed Pharmacies

http://abpharmacy.ca/standards-practice

12.0 Human Resources

http://www.qp.alberta.ca/574.cfm?page=2006_129.cfm&leg_type=Regs&isbncln=9780779758197

12.1 Job Descriptions

Pharmacy Manager:

Insert description

Pharmacist:

Insert description

41
Pharmacy Policies and Procedures Manual – Month, Day, Year

Regulated Pharmacy Technician

Insert description

Pharmacy Assistant:

Insert description

Pharmacy Intern:

Insert description

Pharmacy Student:

Insert description

Other Staff:

Insert description

Volunteers:

Insert description

12.2 Supervising Registered Pharmacy Interns

http://abpharmacy.ca/sites/default/files/PostGradEvalGuide.pdf

12.3 Staffing Levels

Qualifications of staff:

42
Pharmacy Policies and Procedures Manual – Month, Day, Year

Number of staff:

12.4 Dress Code

12.5 Performance Appraisal

12.6 Sick Leave

Procedure:

12.7 Leaves of Absence

Procedure:

12.8 Vacation Requests

Procedure:

12.9 Pandemic Preparedness Plan

Plan for staff:

Plan for store:

12.10 Harassment in the Workplace

43
Pharmacy Policies and Procedures Manual – Month, Day, Year

13.0 Business Operations

13.1 Internet and Electronic Communication

13.2 Opening and Closing Cash

Procedure:

13.3 Charge Accounts

Procedure:

13.4 Cheques
Procedure:

13.5 Staff Purchases

Procedure:

Pricing policies:

13.6 Telephones
Procedure:

13.7 Accounts Receivable

Procedure:

13.8 Accounts Payable

Procedure:

44
Pharmacy Policies and Procedures Manual – Month, Day, Year

13.9 Banking
Procedure:

13.10 Pricing Policies

List drug plans and contact information

13.11 Return Policies

Prescription drugs:

Non-prescription drugs:

Other health care products:

14.0 Contacts
14.1 Manager
Phone number:

E-mail:

14.2 Staff
Name:

Phone number:

E-mail:

14.2.1 Relief Pharmacists

Name:

Phone number:

E-mail:

14.3 Alarm Company

Name:

45
Pharmacy Policies and Procedures Manual – Month, Day, Year

Address:

Phone number:

E-mail:

14.4 Wholesaler(s)
Name:

Address:

Phone number:

E-mail:

14.5 Supplier(s)
Name:

Address:

Phone number:

E-mail:

14.6 Local Physicians

Name:

Address:

Phone number:

Fax number:

14.7 Third Party:

Name:

Phone number:

Provider number:

14.8 Emergency Services

Police:

Fire/Ambulance:

14.8.1 Staff with CPR and First Aid Training

46
Pharmacy Policies and Procedures Manual – Month, Day, Year

47